SCHEMBL7984497

SCHEMBL7984497

CCc1nc(O)c2c(ncn2Cc2cccc(N(C)C)c2)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 1/20 0.41
GAA P10253 1/20 0.35
HPGD P15428 1/20 0.33
ALDH1A1 P00352 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
TSHR P16473 1/20 0.33
GRIN1 Q05586 1/20 0.32
GRIN2B Q13224 1/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
GLA P06280 1/20 0.32
HTT P42858 1/20 0.32
UBE2N P61088 1/20 0.32
PDE4A P27815 1/20 0.32
PDE4B Q07343 1/20 0.32
PDE4C Q08493 1/20 0.32
PDE4D Q08499 1/20 0.32
PDE3B Q13370 1/20 0.32
PDE3A Q14432 1/20 0.32
KMT2A Q03164 1/20 0.32
CYP11B1 P15538 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7974260 0.85 CYP11B1 (0.47) GAAHPGDALDH1A1SMN1; SMN2TSHR
SCHEMBL7984754 0.84 SMN1; SMN2 (0.47) GAASMN1; SMN2L3MBTL1GLAHTT
SCHEMBL7984208 0.84 MAPT (0.39) GAAHPGDALDH1A1SMN1; SMN2TSHR
SCHEMBL7975252 0.83 HPGD (0.45) GAAHPGDALDH1A1SMN1; SMN2TSHR
SCHEMBL7984512 0.82 GAA (0.50) GAAKMT2A
SCHEMBL7985651 0.81 CYP1A2 (0.41) METGAAHPGDALDH1A1SMN1; SMN2
SCHEMBL7984378 0.78 CYP11B1 (0.42) METGAAHPGDALDH1A1SMN1; SMN2
SCHEMBL7988129 0.78 MET (0.44) METGAAHPGDALDH1A1SMN1; SMN2
SCHEMBL7987434 0.77 CYP11B1 (0.42) METHPGDALDH1A1SMN1; SMN2TSHR
SCHEMBL7988660 0.77 CYP11B1 (0.49) GAAHPGDALDH1A1SMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed